Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.
Retsch-Bogart GZ, Quittner AL, Gibson RL, Oermann CM, McCoy KS, Montgomery AB, Cooper PJ. Retsch-Bogart GZ, et al. Among authors: montgomery ab. Chest. 2009 May;135(5):1223-1232. doi: 10.1378/chest.08-1421. Chest. 2009. PMID: 19420195 Free PMC article. Clinical Trial.
BACKGROUND: We assessed the short-term efficacy and safety of aztreonam lysine for inhalation (AZLI [an aerosolized monobactam antibiotic]) in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA) airway infection. ...
BACKGROUND: We assessed the short-term efficacy and safety of aztreonam lysine for inhalation (AZLI [an aerosolized monobactam antibi …
Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A. Aitken ML, et al. Among authors: montgomery ab. JAMA. 1992 Apr 8;267(14):1947-51. JAMA. 1992. PMID: 1548827 Clinical Trial.
CONCLUSIONS: Aerosolized rhDNase appears safe in normal subjects and in adults with cystic fibrosis and may improve lung function with short-term therapy....
CONCLUSIONS: Aerosolized rhDNase appears safe in normal subjects and in adults with cystic fibrosis and may improve lung function with short …
Occupational exposure to aerosolized pentamidine.
Montgomery AB, Corkery KJ, Brunette ER, Leoung GS, Waskin H, Debs RJ. Montgomery AB, et al. Chest. 1990 Aug;98(2):386-8. doi: 10.1378/chest.98.2.386. Chest. 1990. PMID: 2376170
This amount is very small compared to the doses received by the patients in whom long-term adverse effects are few. The greater risk to health care workers is probably transmission of tuberculosis from undiagnosed cases, especially in populations with an increased incidenc …
This amount is very small compared to the doses received by the patients in whom long-term adverse effects are few. The greater risk …
Prophylaxis of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus type 1.
Montgomery AB. Montgomery AB. Semin Respir Infect. 1989 Dec;4(4):311-7. Semin Respir Infect. 1989. PMID: 2697054 Review.
A combination of trimethoprim and sulfamethoxazole is effective prophylactically, although a significant rate of adverse reactions makes long-term prophylaxis difficult. Other oral medications such as dapsone and a combination of pyrimethamine and sulfadoxine are promising …
A combination of trimethoprim and sulfamethoxazole is effective prophylactically, although a significant rate of adverse reactions makes lon …
Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention.
Montgomery AB. Montgomery AB. Semin Respir Infect. 1989 Jun;4(2):102-10. Semin Respir Infect. 1989. PMID: 2664934 Review.
Prophylaxis of PCP is possible with TMP-SMX but the high rate of adverse reactions make long-term therapy difficult. Other oral therapies such as dapsone, pyrimethamine/sulfadoxine are also promising but not yet tested. ...
Prophylaxis of PCP is possible with TMP-SMX but the high rate of adverse reactions make long-term therapy difficult. Other oral thera …